Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2075 of 3546 entries
View as:

To Evaluate Efficacy and Tolerability of Sodium Bicarbonate Toothpaste and Its Effect on Opportunistic or Resistant Organisms

Phase: N/A Priority: Normal
NCT ID: NCT02207400 Org: User:
Start: 08/25/14 End: 04/30/15 Due: 04/30/16

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01485172 Org: User:
Start: 01/31/12 End: 04/30/14 Due: 04/30/15

Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00495014 Org: User:
Start: 06/30/07 End: 12/31/07 Due: 12/31/08

FTIH Study With GSK958108

Phase: N/A Priority: Normal
NCT ID: NCT00664365 Org: User:
Start: 04/12/08 End: 08/22/08 Due: 08/22/09

Risk of Urinary Retention With Retigabine

Phase: N/A Priority: Normal
NCT ID: NCT01462656 Org: User:
Start: 02/28/11 End: 08/31/16 Due: 08/31/17

Topotecan Pharmacokinetic Characterization Study

Phase: N/A Priority: Normal
NCT ID: NCT00361803 Org: User:
Start: 09/12/06 End: 08/09/07 Due: 08/09/08

fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation.

Phase: N/A Priority: Normal
NCT ID: NCT02345187 Org: User:
Start: 10/31/14 End: 04/30/15 Due: 04/30/16

Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03336567 Org: User:
Start: 12/04/17 End: 06/12/18 Due: 06/12/19

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00424255 Org: User:
Start: 12/31/06 End: 11/30/13 Due: 11/30/14

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00970307 Org: User:
Start: 08/13/09 End: 01/27/10 Due: 01/27/11

A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT02014519 Org: User:
Start: 04/24/14 End: 04/24/15 Due: 04/24/16

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00241605 Org: User:
Start: 06/25/03 End: 12/16/05 Due: 12/16/06

A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib

Phase: N/A Priority: Normal
NCT ID: NCT06625489 Org: User:
Start: 10/07/24 End: 11/25/24 Due: 11/25/25

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00547248 Org: User:
Start: 10/22/07 End: 10/07/08 Due: 10/07/09

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT06517875 Org: User:
Start: 02/28/25 End: 11/13/26 Due: 11/13/27

Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.

Phase: N/A Priority: Normal
NCT ID: NCT01400906 Org: User:
Start: 07/20/11 End: 12/12/12 Due: 12/12/13

A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00379756 Org: User:
Start: 05/22/06 End: 05/17/07 Due: 05/17/08

An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT00388180 Org: User:
Start: 12/31/04 End: - Due: -

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT04676724 Org: User:
Start: 01/28/21 End: 02/17/23 Due: 02/17/24

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00197210 Org: User:
Start: 12/31/03 End: 07/31/07 Due: 07/31/08

Advair Pediatric Once-Daily

Phase: N/A Priority: Normal
NCT ID: NCT00920959 Org: User:
Start: 11/30/01 End: 01/31/04 Due: 01/31/05

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Phase: N/A Priority: Normal
NCT ID: NCT00693966 Org: User:
Start: 10/31/99 End: 09/30/04 Due: 09/30/05

A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01160003 Org: User:
Start: 07/29/10 End: 11/05/10 Due: 11/05/11

GSK2239633 FTIH Study

Phase: N/A Priority: Normal
NCT ID: NCT01371812 Org: User:
Start: 03/29/11 End: 07/01/11 Due: 07/01/12

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03207243 Org: User:
Start: 09/14/17 End: 05/15/19 Due: 05/15/20